63 related articles for article (PubMed ID: 31531966)
1. The Genetic Paradigm of Hereditary Breast and Ovarian Cancer (HBOC) in the Afro-Caribbean Population.
Cerbon D; Taylor D; Barreto-Coelho P; Rodriguez E; Schlumbrecht M; Hurley J; George SHL
Crit Rev Oncog; 2024; 29(3):99-112. PubMed ID: 38683157
[TBL] [Abstract][Full Text] [Related]
2. Genetic Counseling, Testing, and Management of HBOC in India: An Expert Consensus Document from Indian Society of Medical and Pediatric Oncology.
Malhotra H; Kowtal P; Mehra N; Pramank R; Sarin R; Rajkumar T; Gupta S; Bapna A; Bhattacharyya GS; Gupta S; Maheshwari A; Mannan AU; Reddy Kundur R; Sekhon R; Singhal M; Smruti BK; Sp S; Suryavanshi M; Verma A
JCO Glob Oncol; 2020 Jul; 6():991-1008. PubMed ID: 32628584
[TBL] [Abstract][Full Text] [Related]
3. Evaluation and comparison of hereditary Cancer guidelines in the population.
Ritchie JB; Bellcross C; Allen CG; Frey L; Morrison H; Schiffman JD; Welch BM
Hered Cancer Clin Pract; 2021 Jul; 19(1):31. PubMed ID: 34274008
[TBL] [Abstract][Full Text] [Related]
4. Genetic testing for familial/hereditary breast cancer-comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany.
Gadzicki D; Evans DG; Harris H; Julian-Reynier C; Nippert I; Schmidtke J; Tibben A; van Asperen CJ; Schlegelberger B
J Community Genet; 2011 Jun; 2(2):53-69. PubMed ID: 22109790
[TBL] [Abstract][Full Text] [Related]
5. The Evolution of Genetic Testing from Focused Testing to Panel Testing and from Patient Focused to Population Testing: Are We There Yet?
Gima L; Solomon I; Hampel H
Clin Colon Rectal Surg; 2024 May; 37(3):133-139. PubMed ID: 38606045
[TBL] [Abstract][Full Text] [Related]
6. A novel ribosomal protein S20 variant in a family with unexplained colorectal cancer and polyposis.
Thompson BA; Snow AK; Koptiuch C; Kohlmann WK; Mooney R; Johnson S; Huff CD; Yu Y; Teerlink CC; Feng BJ; Neklason DW; Cannon-Albright LA; Tavtigian SV
Clin Genet; 2020 Jun; 97(6):943-944. PubMed ID: 32424863
[No Abstract] [Full Text] [Related]
7. Priority of Risk (But Not Perceived Magnitude of Risk) Predicts Improved Sun-Protection Behavior Following Genetic Counseling for Familial Melanoma.
Taber JM; Aspinwall LG; Drummond DM; Stump TK; Kohlmann W; Champine M; Cassidy P; Leachman SA
Ann Behav Med; 2021 Feb; 55(1):24-40. PubMed ID: 32415830
[TBL] [Abstract][Full Text] [Related]
8. Standards-Based Clinical Decision Support Platform to Manage Patients Who Meet Guideline-Based Criteria for Genetic Evaluation of Familial Cancer.
Del Fiol G; Kohlmann W; Bradshaw RL; Weir CR; Flynn M; Hess R; Schiffman JD; Nanjo C; Kawamoto K
JCO Clin Cancer Inform; 2020 Jan; 4():1-9. PubMed ID: 31951474
[TBL] [Abstract][Full Text] [Related]
9. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers.
Mavaddat N; Antoniou AC; Mooij TM; Hooning MJ; Heemskerk-Gerritsen BA; ; Noguès C; Gauthier-Villars M; Caron O; Gesta P; Pujol P; Lortholary A; ; Barrowdale D; Frost D; Evans DG; Izatt L; Adlard J; Eeles R; Brewer C; Tischkowitz M; Henderson A; Cook J; Eccles D; ; van Engelen K; Mourits MJE; Ausems MGEM; Koppert LB; Hopper JL; John EM; Chung WK; Andrulis IL; Daly MB; Buys SS; ; Benitez J; Caldes T; Jakubowska A; Simard J; Singer CF; Tan Y; Olah E; Navratilova M; Foretova L; Gerdes AM; Roos-Blom MJ; Van Leeuwen FE; Arver B; Olsson H; Schmutzler RK; Engel C; Kast K; Phillips KA; Terry MB; Milne RL; Goldgar DE; Rookus MA; Andrieu N; Easton DF; ; ;
Breast Cancer Res; 2020 Jan; 22(1):8. PubMed ID: 31948486
[TBL] [Abstract][Full Text] [Related]
10. Targeted germline sequencing of patients with three or more primary melanomas reveals high rate of pathogenic variants.
Li C; Liu T; Tavtigian SV; Boucher K; Kohlmann W; Cannon-Albright L; Grossman D
Melanoma Res; 2020 Jun; 30(3):247-251. PubMed ID: 31567591
[TBL] [Abstract][Full Text] [Related]
11. Serum high-density lipoprotein level and prognosis of ovarian cancer.
Hongyan J; Pengcheng C; Chihong Z; Xiaoqian Q; Danying W; Jianguo F
Medicine (Baltimore); 2023 Oct; 102(41):e35561. PubMed ID: 37832112
[TBL] [Abstract][Full Text] [Related]
12. Universal Germline-Genetic Testing for Breast Cancer: Implementation in a Rural Practice and Impact on Shared Decision-Making.
Shelton C; Ruiz A; Shelton L; Montgomery H; Freas K; Ellsworth RE; Poll S; Pineda-Alvarez D; Heald B; Esplin ED; Nielsen SM
Ann Surg Oncol; 2024 Jan; 31(1):325-334. PubMed ID: 37814187
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Americans reporting a family history of cancer indicative of increased cancer risk: Estimates from the 2015 National Health Interview Survey.
Kumerow MT; Rodriguez JL; Dai S; Kolor K; Rotunno M; Peipins LA
Prev Med; 2022 Jun; 159():107062. PubMed ID: 35460723
[TBL] [Abstract][Full Text] [Related]
14. Retrospective assessment of barriers and access to genetic services for hereditary cancer syndromes in an integrated health care delivery system.
Muessig KR; Zepp JM; Keast E; Shuster EE; Reyes AA; Arnold B; Ingphakorn C; Gilmore MJ; Kauffman TL; Hunter JE; Knerr S; Feigelson HS; Goddard KAB
Hered Cancer Clin Pract; 2022 Feb; 20(1):7. PubMed ID: 35144679
[TBL] [Abstract][Full Text] [Related]
15. Using a Tailored Digital Health Intervention for Family Communication and Cascade Genetic Testing in Swiss and Korean Families With Hereditary Breast and Ovarian Cancer: Protocol for the DIALOGUE Study.
Kim S; Aceti M; Baroutsou V; Bürki N; Caiata-Zufferey M; Cattaneo M; Chappuis PO; Ciorba FM; Graffeo-Galbiati R; Heinzelmann-Schwarz V; Jeong J; Jung MM; Kim SW; Kim J; Lim MC; Ming C; Monnerat C; Park HS; Park SH; Pedrazzani CA; Rabaglio M; Ryu JM; Saccilotto R; Wieser S; Zürrer-Härdi U; Katapodi MC
JMIR Res Protoc; 2021 Jun; 10(6):e26264. PubMed ID: 34114954
[TBL] [Abstract][Full Text] [Related]
16. Identification of women at risk for hereditary breast and ovarian cancer in a sample of 1000 Slovenian women: a comparison of guidelines.
Kotnik U; Peterlin B; Lovrecic L
BMC Cancer; 2021 Jun; 21(1):665. PubMed ID: 34082720
[TBL] [Abstract][Full Text] [Related]
17. Interventions Facilitating Family Communication of Genetic Testing Results and Cascade Screening in Hereditary Breast/Ovarian Cancer or Lynch Syndrome: A Systematic Review and Meta-Analysis.
Baroutsou V; Underhill-Blazey ML; Appenzeller-Herzog C; Katapodi MC
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33672149
[TBL] [Abstract][Full Text] [Related]
18. Implementing Cancer Genomics in State Health Agencies: Mapping Activities to an Implementation Science Outcome Framework.
Green RF; Kumerow MT; Rodriguez JL; Addie S; Beachy SH; Senier L
Public Health Genomics; 2020; 23(5-6):218-229. PubMed ID: 32942283
[TBL] [Abstract][Full Text] [Related]
19. Population prevalence of individuals meeting criteria for hereditary breast and ovarian cancer testing.
Greenberg S; Buys SS; Edwards SL; Espinel W; Fraser A; Gammon A; Hafen B; Herget KA; Kohlmann W; Roundy C; Sweeney C
Cancer Med; 2019 Nov; 8(15):6789-6798. PubMed ID: 31531966
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
